admin – Page 6232 – Get News Story

Head and Neck Cancer Clinical Trials Assessment 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA and Companies by DelveInsight

“Head and Neck Cancer Clinical Trials”

Head and Neck Cancer companies are Innate Pharma, GlaxoSmithKline, Debiopharm, Checkpoint Therapeutics, Quadriga BioSciences, Palleon Pharmaceuticals, Klus Pharma, Bicycle Therapeutics, CSPC ZhongQi Pharmaceutical Technology, Memgen, I-Mab Biopharma, Intensity Therapeutics, Wellmaker Bio, SN BioScience, Carisma Therapeutics, Genentech, and others.

(Albany, USA) DelveInsight’s ‘Head and Neck Cancer Pipeline Insight 2024’ report provides comprehensive global coverage of available, marketed, and pipeline head and neck cancer therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the head and neck cancer pipeline domain.

Request for a free sample report @ Head and Neck Cancer Pipeline Analysis

Key Takeaways from the Head and Neck Cancer Pipeline Report

DelveInsight’s head and neck cancer pipeline report depicts a robust space with 100+ active players working to develop 120+ pipeline therapies for head and neck cancer treatment.
Key head and neck cancer companies such as Innate Pharma, GlaxoSmithKline, Debiopharm, Checkpoint Therapeutics, Quadriga BioSciences, Palleon Pharmaceuticals, Klus Pharma, Bicycle Therapeutics, CSPC ZhongQi Pharmaceutical Technology, Memgen, I-Mab Biopharma, Intensity Therapeutics, Wellmaker Bio, SN BioScience, Carisma Therapeutics, Genentech, Pionyr Immunotherapeutics, Palleon Pharmaceuticals, SN BioScience, Bicycle Therapeutics, Inhibrx, Celldex Therapeutics, Carisma Therapeutics Inc, BioAtla, Jacobio Pharmaceuticals, Compugen, GeoVax, CytomX Therapeutics, PNP Therapeutics, Galectin Therapeutics, Cyteir Therapeutics, Merck KGaA, Boehringer Ingelheim, Transgene, iTeos Therapeutics SA, IntraGel Therapeutics, Incyte Corporation, Cue Biopharma, Rubius Therapeutics, Alkermes, Corregene Biotechnology, NanoCarrier, Kura Oncology, Betta Pharmaceuticals, Arcus Biosciences, Taiho Pharmaceutical, Astex Pharmaceuticals, Bayer HealthCare, Roche, Vaccinex, Pfizer, BioNTech, Purple Biotech, Novartis Oncology, Macrogenics, Aveta Biomics, Cellectar Biosciences, Nanobiotix, Nektar Therapeutics, Istari Oncology, Nanobiotix, Aspyrian Therapeutics, and others are evaluating new head and neck cancer drugs to improve the treatment landscape.
Promising head and neck cancer pipeline therapies such as Niraparib, Xevinapant, , CK-301, QBS10072S, A166, E-602, BT5528, RAPA-201, Mitoxantrone Hydrochloride, MEM-288, TJ004309, SNB-101, INT230-6, CT-0508, WM-S1-030, CDX-1140, PY159, MCLA-129, INBRX-106, Autogene cevumeran, JAB-3068, CAB-ROR2-ADC, CX-2029, Ad/PNP, COM701, Eftilagimod alpha, CYT-0851, GR-MD-02, TG4050, BI 765063, TumoCure, EOS-448, Epacadostat, RTX-321, CUE-101, ALKS 4230, CRTE7A2-01, NC-6004, Tipifarnib, MCLA-129, Zimberelimab, HLX10 Plus HLX07, Tolinapant, BAY1905254, OSI-774, VX15/2503, Palbociclib, Olaparib, NT219, BNT113, Buparlisib, Retifanlimab, Avelumab, APG-157, CLR 131, NBTXR3, Evorpacept, Dostarlimab, NKTR-214, IK-175, Lerapolturev, NBTXR3, Gedeptin, RM-1995, Atezolizumab and others are under different phases of head and neck cancer clinical trials.
In September 2022, NANOBIOTIX announced randomization of the first patient in Asia in NANORAY-312, a global Phase III registrational trial evaluating NBTXR3 for the treatment of elderly patients with locally advanced head and neck squamous cell carcinoma who are ineligible for platinum-based chemotherapy.
In August 2022, Genexine announced the dosing of the first patient in Phase II clinical trial using triple combination therapy in patients with recurrent/metastatic HNSCC. The combination therapy consists of two of Genexine’s proprietary drugs, GX-188E (a first-in-class therapeutic DNA vaccine), GX-I7 (a first-in-class long-acting interleukin 7), and Opdivo (nivolumab), a marketed PD-1 immune checkpoint inhibitor.
In May 2022, Calliditas announced that it had initiated Phase II head and neck cancer therapy trial. The trial will analyze the impact of setanaxib plus pembrolizumab in patients with CAF-density tumors. Calliditas Therapeutics has randomized the first subject in the proof-of-concept Phase II clinical trial of setanaxib (GKT831) in individuals with squamous cell carcinoma of the head and neck (SCCHN).

Request a sample and discover the recent advances in head and neck cancer treatment drugs @ Head and Neck Cancer Treatment Market

Head and Neck Cancer Overview

Head and neck cancer is a collective term for several different types of cancer. Cancers of the head and neck are classified according to where they begin. The mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands are all included. Squamous cell carcinoma of the head and neck is the most common type of head and neck cancer (HNSCCA). The majority of HNSCCA begins in the layer of flat cells (the epithelium) that lines the upper aerodigestive tract structures such as the mouth, throat, and voice box.

Head and neck cancer symptoms include a lump in the neck or a sore in the mouth or throat that does not heal, a persistent sore throat, difficulty swallowing, and a change or hoarseness in voice; however, these head and neck cancer symptoms can also be caused by other, less severe illnesses.

For head and neck diagnosis, physical examination/blood and urine tests, endoscopy, biopsy, biomarker testing of the tumor, X-ray/barium swallow, panoramic radiograph, ultrasound, magnetic resonance imaging, bone scan, and other tests are used.

Learn more about the emerging head and neck cancer pipeline therapies @ Head and Neck Cancer Drugs and Therapies

Head and Neck Cancer Therapeutics Assessment

Over 100+ prominent companies are actively involved in the development of therapies for Head and Neck cancer. Among these, certain companies have positioned themselves at the forefront by advancing their Head and Neck cancer drug candidates to the most advanced stage, namely Phase III.

For further information on the head and neck cancer pipeline therapeutics, reach out @ Head and Neck Cancer Drugs and Therapeutic Assessment

Scope of the Head and Neck Cancer Pipeline Report

Coverage: Global
Therapeutic Assessment By Product Type: Mono, Combination, Mono/Combination
Therapeutic Assessment By Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Therapeutics Assessment By Route of Administration: Inhalation, Intranasal, Intravenous, Oral, Parenteral, Subcutaneous
Therapeutics Assessment By Molecule Type: Antibody, Antisense oligonucleotides, Immunotherapy, Monoclonal antibody, Peptides, Protein, Recombinant protein, Small molecule, Stem cell, Vaccine
Therapeutics Assessment By Mechanism of Action: Antibody-dependent cell cytotoxicity, NK cell lectin-like receptor subfamily C antagonists, Poly(ADP-ribose) polymerase 1 inhibitors, Poly(ADP-ribose) polymerase 2 inhibitors, Inhibitor of apoptosis protein inhibitors, T lymphocyte stimulants, Aryl hydrocarbon receptor antagonists, DNA topoisomerase I inhibitors; CD40 ligand expression stimulants; Cell death stimulants; Immunologic cytotoxicity, Galectin 3 inhibitors, CD40 antigen stimulants
Key Head and Neck Cancer Companies: Innate Pharma, GlaxoSmithKline, Debiopharm, Checkpoint Therapeutics, Quadriga BioSciences, Palleon Pharmaceuticals, Klus Pharma, Bicycle Therapeutics, CSPC ZhongQi Pharmaceutical Technology, Memgen, I-Mab Biopharma, Intensity Therapeutics, Wellmaker Bio, SN BioScience, Carisma Therapeutics, Genentech, Pionyr Immunotherapeutics, Palleon Pharmaceuticals, SN BioScience, Bicycle Therapeutics, Inhibrx, Celldex Therapeutics, Carisma Therapeutics Inc, BioAtla, Jacobio Pharmaceuticals, Compugen, GeoVax, CytomX Therapeutics, PNP Therapeutics, Galectin Therapeutics, Cyteir Therapeutics, Merck KGaA, Boehringer Ingelheim, Transgene, iTeos Therapeutics SA, IntraGel Therapeutics, Incyte Corporation, Cue Biopharma, Rubius Therapeutics, Alkermes, Corregene Biotechnology, NanoCarrier, Kura Oncology, Betta Pharmaceuticals, Arcus Biosciences, Taiho Pharmaceutical, Astex Pharmaceuticals, Bayer HealthCare, Roche, Vaccinex, Pfizer, BioNTech, Purple Biotech, Novartis Oncology, Macrogenics, Aveta Biomics, Cellectar Biosciences, Nanobiotix, Nektar Therapeutics, Istari Oncology, Nanobiotix, Aspyrian Therapeutics and others.
Key Head and Neck Cancer Pipeline Therapies: Niraparib, Xevinapant, , CK-301, QBS10072S, A166, E-602, BT5528, RAPA-201, Mitoxantrone Hydrochloride, MEM-288, TJ004309, SNB-101, INT230-6, CT-0508, WM-S1-030, CDX-1140, PY159, MCLA-129, INBRX-106, Autogene cevumeran, JAB-3068, CAB-ROR2-ADC, CX-2029, Ad/PNP, COM701, Eftilagimod alpha, CYT-0851, GR-MD-02, TG4050, BI 765063, TumoCure, EOS-448, Epacadostat, RTX-321, CUE-101, ALKS 4230, CRTE7A2-01, NC-6004, Tipifarnib, MCLA-129, Zimberelimab, HLX10 Plus HLX07, Tolinapant, BAY1905254, OSI-774, VX15/2503, Palbociclib, Olaparib, NT219, BNT113, Buparlisib, Retifanlimab, Avelumab, APG-157, CLR 131, NBTXR3, Evorpacept, Dostarlimab, NKTR-214, IK-175, Lerapolturev, NBTXR3, Gedeptin, RM-1995, Atezolizuma, and others.

Dive deep into rich insights for new drugs for head and neck cancer treatment, visit @ Head and Neck Cancer Clinical Trials and FDA Approvals

Table of Contents

Report Introduction
Executive Summary
Head and Neck Cancer Current Treatment Patterns
Head and Neck Cancer – DelveInsight’s Analytical Perspective
Therapeutic Assessment
Head and Neck Cancer Late-Stage Products (Phase-III)
Head and Neck Cancer Mid-Stage Products (Phase-II)
Early Stage Products (Phase-I)
Pre-clinical Products and Discovery Stage Products
Inactive Products
Dormant Products
Head and Neck Cancer Discontinued Products
Head and Neck Cancer Product Profiles
Head and Neck Cancer Companies
Head and Neck Cancer Drugs
Dormant and Discontinued Products
Head and Neck Cancer Unmet Needs
Head and Neck Cancer Future Perspectives
Head and Neck Cancer Analyst Review
Appendix
Report Methodology

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432, Las Vegas NV 89107
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Head and Neck Cancer Clinical Trials Assessment 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA and Companies by DelveInsight

Top Real Estate Agent in Menifee, CA Shares Tips for Maximizing Property Value in Competitive Market

Christian Rios, a top real estate agent in Menifee, CA, offers expert strategies for homeowners looking to maximize their property value in a notably competitive market. With Southern California’s real estate landscape undergoing significant changes, Christin provides essential tips to help sellers navigate this dynamic environment effectively.

“Proper pricing is the cornerstone of real estate sales success,” says Christian. Determining the right listing price is crucial and involves a detailed analysis of market trends and comparable property prices. As a trusted Realtor in Menifee, CA, Christian leverages his extensive market knowledge to set prices that attract buyers while ensuring a profitable sale for sellers.

Enhancing curb appeal is another critical advice from Christian. “First impressions are incredibly important. Simple enhancements like fresh landscaping or a new coat of paint can significantly impact how a property is perceived,” he explains. These changes not only attract more buyers but can also substantially increase the property’s sale price.

Decluttering and depersonalizing the space are additional steps that Christian emphasizes. “Buyers need to envision themselves in the home. Clearing out personal items and clutter can make the space more inviting and can make a big difference in how quickly the property sells,” advises Christian. As a Realtor agent in Menifee, CA, he understands that presenting a clean, neutral environment is key to engaging potential buyers.

For sellers in the competitive Menifee market, working with a seasoned professional like Christian is invaluable. “My experience and understanding of what drives buyer decisions in this area allow me to guide sellers through the process smoothly and successfully,” states Christian.

Homeowners looking to sell in Menifee are encouraged to contact Christian Rios, a professional real estate selling agent in Menifee, CA, for personalized service and expert guidance. With his proven strategies and deep local expertise, Christian can help you achieve the best possible outcome in today’s market.

Visit http://www.christianriosproperties.com/ to learn more about how he can assist you in maximizing your property’s value and to schedule a consultation. Trust Christian Rios, a dedicated Realtor agents in Menifee, CA, to navigate you through the selling process with confidence and success.

Media Contact
Company Name: Christian Rios | Real Estate Agent in Menifee CA
Contact Person: Christian Rios
Email: Send Email
Phone: +1 (951) 482-7440
Address:36636 Obaria Way
City: Menifee
State: California 92532
Country: United States
Website: https://christianriosproperties.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Top Real Estate Agent in Menifee, CA Shares Tips for Maximizing Property Value in Competitive Market

Nick Padlo, Local Business Leader and Mental Health Advocate, Shares Visionary Ideas on Addiction Recovery in TED Talk

“TEDx Talks”

Applying the recovery toolkit to mental health curricula

Jacksonville, FL – Nick Padlo, a leader in the local business community, passionate health advocate, and founder of Sophros Recovery (https://www.sophrosrecoverytampa.com/), recently gave an inspiring TED Talk (https://www.youtube.com/watch?v=WyvPuCzn_7Q) in Tampa Bay, FL. In his talk, he highlighted the importance of incorporating addiction recovery education into mainstream education. Padlo’s personal story is one of service, commitment, academic achievements, and business success, adding depth to his call for a shift in society’s approach to challenges regarding health, well-being, and recovery.

Released this week, Padlo’s TED Talk focuses on the relevance of addiction recovery principles. Drawing from his struggles with depression, anxiety, and substance abuse, he stresses the value of recovery strategies. Critical elements discussed include Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), mindfulness techniques, effective communication methods, and the spiritual aspects of the Alcoholics Anonymous 12-step program.

“I see a future where everyone has access to the education of self, and one where you don’t have to be an alcoholic to get it,” says Padlo.

Padlo’s journey has been marked by unique experiences and unwavering dedication. Following his graduation from the prestigious United States Military Academy at West Point, where he led the Honor Committee, Padlo’s service in the US Army was distinguished through his earned accolades, including the Bronze Star and Combat Action Badge during his deployments in Afghanistan and Iraq. His pursuit of education at Stanford University’s Graduate School of Business and his subsequent rise to the position of CEO in a rapidly growing company listed on Inc. 1000 serves as a testament to his resilience and drive.

Padlo’s foray into substance abuse treatment was not just a personal journey but a mission to make a difference in the lives of others. Today, Sophros Recovery — which recently expanded into the Tampa, FL area — serves as a beacon of hope for individuals throughout Florida, providing them with the necessary tools and unwavering encouragement to start their recovery journey.

By pushing for the inclusion of recovery principles in education and highlighting therapists as collaborators in mental resilience, Padlo exemplifies a compassionate leadership ethos and societal change. With his background and strong advocacy for health issues, Padlos’s TED Talk symbolizes a significant moment in ongoing conversations about addiction recovery and mental well-being.

About Nick Padlo, Founder and CEO of Sophros Recovery

Nick Padlo is a small business leader, entrepreneur, and native of Jacksonville Florida. He received his undergraduate degree from the United States Military Academy (West Point), where he served as the Chairman of the Honor Committee. After West Point, Nick served for 5 years in the United States Army. Where he spent 27 months in combat operations between Afghanistan and Iraq, earning the Bronze Star and Combat Action Badge. He attended Stanford University for business school and later went on to become CEO of an Inc1000 growth company. His move into substance abuse treatment is a result of his personal battle with depression, anxiety, and substance use disorder. After getting treatment himself, Nick defined his personal mission as helping others through similarly dark times. He believes that everyone can find their way back, regain their lives, and live a life free of suffering. Sophros (www.sophrosrecovery.com) was designed to be just that place, where clients across Florida can develop a set of tools that can help them establish their own personal road to recovery.

Media Contact
Company Name: Otter Public Relations
Contact Person: Anna Kate Womack
Email: Send Email
City: ORLANDO
State: FL
Country: United States
Website: www.otterpr.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Nick Padlo, Local Business Leader and Mental Health Advocate, Shares Visionary Ideas on Addiction Recovery in TED Talk

Revolutionising Leather Care with Eco-Friendly Dyeing Methods By The Leather Colour Doctor

new eco-friendly dyeing methods, providing a neutral and factual report on the company’s latest innovation and its broader impact on the textile industry.

The Leather Colour Doctor is pleased to announce the introduction of a new range of eco-friendly dyeing methods designed to provide sustainable solutions for leather restoration and maintenance. This innovative approach aligns with the growing demand for environmentally conscious practices within the textile industry.

Addressing Environmental Concerns in Dyeing

The textile industry, known for its significant environmental impact, particularly through the use of synthetic dyes, is witnessing a shift towards more sustainable practices. Conventional dyes and traditional dyeing methods often rely on toxic chemicals and energy-intensive processes, leading to substantial chemical waste and environmental harm. In contrast, The Leather Colour Doctor’s eco-friendly dyeing methods utilize natural dyes and advanced processes that minimize the use of harmful substances.

The Eco-Friendly Dyeing Process

The Leather Colour Doctor’s new eco-friendly dyes are derived from natural materials such as natural indigo and biosynthetic indigo blue. These dyes are produced enzymatically, avoiding the use of harsh chemicals and reducing overall energy consumption. This method ensures better dye fixation and uniform dyeing, resulting in high-quality dyed fabric without the adverse effects associated with conventional dyes.

Benefits of the New Dyeing Methods

Environmental Impact: The eco-friendly dyeing methods significantly reduce chemical waste and energy usage. By utilizing natural dyes and avoiding toxic chemicals, The Leather Colour Doctor’s products contribute to a more sustainable textile production process.
Health and Safety: The absence of harmful chemicals in these dyes ensures a safer dyeing process for both workers and consumers. The non-toxic nature of these dyes promotes healthier practices within the textile industry.
High-Quality Results: The advanced dyeing techniques ensure that the dyed fabric retains its color and quality over time. The process avoids excess dyes and unfixed dye, preventing issues such as fading and color bleeding.

Real-World Applications

Several textile mills and manufacturers have already adopted The Leather Colour Doctor’s eco-friendly dyeing methods with positive results. For instance, a European textile mill reported a 30% reduction in energy consumption and a significant decrease in chemical waste after switching to these sustainable dyes. The mill’s products, including high-end leather goods and textile fibers, maintained their quality and color vibrancy, demonstrating the effectiveness of these eco-friendly dyes.

Industry Impact

The Leather Colour Doctor’s introduction of eco-friendly dyeing methods is set to make a significant impact on the textile industry. As more manufacturers and brands adopt sustainable dyeing practices, the overall environmental footprint of the industry is expected to decrease. This shift towards eco-friendly solutions is part of a broader effort to promote sustainability and reduce the adverse effects of industrial processes on the environment.

Invitation to Learn More

The Leather Colour Doctor invites industry stakeholders, textile manufacturers, and consumers to learn more about these innovative eco-friendly dyeing methods. Detailed information about the new dye range and its benefits is available on The Leather Colour Doctor’s website.

Additionally, the company will host a webinar on sustainable leather care practices, featuring expert discussions on eco-friendly dyes and their application. Interested parties are encouraged to register for the webinar to gain insights into the latest trends and best practices in the industry.

Conclusion

The Leather Colour Doctor remains committed to leading the industry in sustainable leather care solutions. The launch of these eco-friendly dyes marks a significant step towards reducing the environmental impact of leather dyeing and promoting safer, healthier practices for all involved.

For more information, please visit The Leather Colour Doctor website.

Media Contact
Company Name: The Leather Colour Doctor
Contact Person: John Appleby
Email: Send Email
Address:Unit 2 Front Street Industrial Estate, Wheatley Hill
State: Co Durham, DH63QZ
Country: United Kingdom
Website: https://www.theleathercolourdoctor.co.uk

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Revolutionising Leather Care with Eco-Friendly Dyeing Methods By The Leather Colour Doctor

Multiple Sclerosis Clinical Trials Assessment 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA and Companies by DelveInsight

“Multiple Sclerosis Clinical Trials”

Multiple Sclerosis Companies are TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline,, AstraZeneca, and others.

(Albany, USA) DelveInsight’s Multiple Sclerosis Pipeline report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape.

“Multiple sclerosis Pipeline Insight, 2024” report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Multiple sclerosis pipeline landscape is provided which includes the disease overview and Multiple sclerosis treatment guidelines. The assessment part of the report embraces, in depth Multiple sclerosis commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Multiple sclerosis collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Request a sample and discover the recent advances in Multiple Sclerosis Treatment Drugs @ Multiple Sclerosis Pipeline Outlook

Key Takeaways from the Multiple Sclerosis Pipeline Report

DelveInsight’s Multiple Sclerosis pipeline report depicts a robust space with 80+ active players working to develop 85+ pipeline therapies for Multiple Sclerosis treatment.
The leading companies working in the Multiple Sclerosis Market include TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others.
Promising Multiple Sclerosis Pipeline Therapies in the various stages of development rHIgM22, CNTO 1275, Interferon beta-1a (Rebif), alemtuzumab, IMS001, and others.
In November 2023: Hoffmann-La Roche announced a study of Phase 3 clinical trials for Ocrelizumab and Fingolimod. This double-blind, study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a duration of at least 96 weeks.
October 2023: Hoffmann-La Roche announced a study of phase 3 clinical trials for Ocrelizumab. This double-blind, study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a duration of at least 96 weeks.
September 2023: ImStem Biotechnology announced a study of phase 1 clinical trials for IMS001. This is a Phase 1 study of IMS001, given as a single dose to subjects with Multiple Sclerosis who experience inadequate response and/or intolerability to disease modifying treatments. IMS001 is a human embryonic cell derived (hESC) mesenchymal stem cell (MSC). MSCs have the potential to modulate disease course.

Dive deep into rich insights for new drugs for Multiple Sclerosis Treatment, Visit @ Multiple Sclerosis Treatment Market

Multiple Sclerosis Overview

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, specifically the brain and spinal cord. It occurs when the immune system mistakenly attacks the protective myelin sheath covering nerve fibers, leading to communication problems between the brain and the rest of the body. Over time, the disease can cause permanent damage or deterioration of the nerves themselves.

Multiple sclerosis manifests in various forms, with relapsing-remitting Multiple sclerosis (RRMS) being the most common. RRMS is characterized by episodes of new or worsening symptoms (relapses) followed by periods of partial or complete recovery (remissions). Other types include primary progressive Multiple sclerosis (PPMS), which involves steady progression without relapses, and secondary progressive Multiple sclerosis (SPMS), which follows an initial relapsing-remitting course and then transitions to a progressive form.

Symptoms of Multiple sclerosis vary widely and can include fatigue, numbness or tingling, muscle weakness, coordination and balance issues, vision problems, and cognitive changes. The exact cause of Multiple sclerosis remains unknown, though it is believed to result from a combination of genetic and environmental factors.

There is no cure for Multiple sclerosis, but treatments are available to manage symptoms, reduce relapses, and slow disease progression. These treatments include disease-modifying therapies, corticosteroids, physical therapy, and various medications to address specific symptoms. Early diagnosis and intervention are crucial for improving long-term outcomes.

Find out more about Multiple Sclerosis Therapeutics Assessment @ Multiple Sclerosis Clinical Trials and FDA Approvals

Multiple Sclerosis Emerging Drugs Profile

Ublituximab: TG Therapeutics
IMU-838: Immunic
ATA188: Atara Biotherapeutics
ANK-700: ANOKION

Multiple Sclerosis Pipeline Therapeutics Assessment

There are approx. 80+ key companies which are developing the Multiple sclerosis therapies. The Multiple sclerosis companies which have their Multiple sclerosis drug candidates in the most advanced stage, i.e. preregistration include, TG Therapeutics.

DelveInsight’s Multiple Sclerosis Pipeline Report covers around 100+ products under different phases of clinical development like

Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates

Request for Sample Report @ Multiple Sclerosis Drugs Assessment

Route of Administration

Multiple sclerosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Oral
Parenteral
Intravenous
Subcutaneous
Topical.

Molecule Type

Multiple Sclerosis Products have been categorized under various Molecule types such as

Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy
Product Type

Learn more about the emerging Multiple Sclerosis Pipeline Therapies @ Multiple Sclerosis Clinical Trials Assessment

Scope of the Multiple Sclerosis Pipeline Report

Coverage- Global
Multiple Sclerosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Multiple Sclerosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Multiple Sclerosis Companies- TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others.
Multiple Sclerosis Pipeline Therapies- HIgM22, CNTO 1275, Interferon beta-1a (Rebif), alemtuzumab, IMS001, and others

Table of Content

Introduction
Executive Summary
Multiple sclerosis: Overview
Pipeline Therapeutics
Therapeutic Assessment
Multiple sclerosis – DelveInsight’s Analytical Perspective
Late Stage Products (Preregistration)
Ublituximab: TG Therapeutics
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
EHP 101: Emerald Health Pharmaceuticals
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
ASLAN 003: ASLAN Pharmaceuticals
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Lucid MS: FSD Pharma
Drug profiles in the detailed report…..
Inactive Products
Multiple sclerosis Key Companies
Multiple sclerosis Key Products
Multiple sclerosis- Unmet Needs
Multiple sclerosis- Market Drivers and Barriers
Multiple sclerosis- Future Perspectives and Conclusion
Multiple sclerosis Analyst Views
Multiple sclerosis Key Companies
Appendix

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Multiple Sclerosis Clinical Trials Assessment 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA and Companies by DelveInsight

Rome In A Day Handyman Services Shares Tips for Tackling Home Repair Projects

Rome In A Day Handyman Services is a top-rated handyman service company. In a recent update, the company shared tips for tackling home repair projects.

Colorado Springs, CO – June 28, 2024 – In a website post, Rome In A Day Handyman Services shared tips for tackling home repair projects.

The local handyman Colorado Springs said that when embarking on a home repair project, it is critical to gather all the required tools and materials beforehand. This includes not only the obvious items like hammers, screwdrivers, and nails but also any specific materials needed for the task at hand, such as paint or caulking. This can help homeowners avoid frustrating interruptions and ensure a smoother workflow from start to finish.

The professional handyman Colorado Springs affirmed that proper preparation is paramount when tackling any home repair project. This involves not only preparing the area to be worked on but also mentally preparing for the task ahead. Taking the time to clear the workspace, protect surrounding surfaces, and gather any relevant instructions or tutorials can significantly streamline the repair process.

The licensed handyman Colorado Springs advised that knowing when to call in professional help is key to avoiding DIY disasters. While many home repair projects can be tackled by the average homeowner with the right tools and know-how, there are certain tasks that are best left to the experts. Recognizing one’s limitations and seeking professional assistance when needed can save both time and money in the long run.

About Rome In A Day Handyman Services

Rome In A Day Handyman Services is a leading handyman service company. The team is comprised of skilled technicians with extensive experience in the handyman industry. From minor fixes to major renovations, they are equipped to tackle projects of all sizes with efficiency and expertise. With a commitment to excellence, Rome In A Day Handyman Services strives to exceed expectations and deliver outstanding results on every job.

Rome In A Day Handyman Services Colorado Springs

526 W Pikes Peak Ave, Colorado Springs, CO 80905

(719) 881-8880

Media Contact
Company Name: Rome In A Day Handyman Services Colorado Springs
Contact Person: Romeo Alvarenga
Email: Send Email
Phone: (719) 881-8880
City: Colorado Springs
State: Colorado
Country: United States
Website: https://romeinadayhandymanservices.com/

Magicycle Launches Ocelot Pro 2.0 with Switchable Torque Sensor

Los Angeles, CA – Magicycle is really proud to introduce its newest electric bike, the Ocelot Pro 2.0, fitted with a powerful 1500W motor that will power riders up to 28mph and a voluminous 52V 20Ah battery for an impressive range of up to 120 miles on one charge. Magicycle focuses on producing the best fat tire electric bikes for riders of all kinds. Our electric bikes strive to exert effort in answering all needs of any e-bike enthusiast, either off-road adventure or daily commuting and are definitely suited to people looking to adventure through the wild or boulevard cruise and weekend rides.

This torque sensor will smooth out the ride and make it feel more natural because it changes the motor’s output based on how hard riders are pedaling. The company developed the Ocelot Pro 2.0 in response to the growing demand for higher performance and longer ranges in the electric bike market. With superior power, speed, and endurance combined with intelligent pedal assist, the Ocelot Pro 2.0 is a real commuting, leisure ride, and long-travel solution.

What’s New？

New Color

The Ocelot Pro 2.0 now comes in a stunning new color: Maroon. This sophisticated shade exudes elegance and uniqueness, making it a standout choice for riders who want to make a stylish statement. The rich, deep hue of Maroon not only adds a touch of luxury to the bike’s design but also ensures it remains timelessly fashionable. Perfect for those who appreciate both high performance and aesthetic appeal, the Maroon Ocelot Pro 2.0 is designed to turn heads and reflect riders’ distinctive taste, making every ride an experience in both function and form.

New Production Process

The down tube of the Ocelot Pro 2.0 is formed by a multi-cavity oil injection process. The thickness of the tube wall is designed to be 4-5mm, whereas the e-bike industry usually has a thickness of only 3mm with a single cavity. This technology solves the problems of insufficient strength of the step-thru model down tube in the bike industry, soft frame, handlebar shaking, and rear wheel wobbling when going downhill or getting off the bike.

New Sensor

The torque sensor installed on the Magicycle Ocelot Pro 2.0 is advanced technology applied to an electric bicycle. It works intelligently in sensing the force a rider exudes on the pedals and adjusts the motor output accordingly. This means the motor gives more power when pedaling harder and reduces motor output when one pedals lightly, thereby providing a smoother and more natural ride.

The Advantages of Advanced Torque Sensors Compared to Traditional Cadence Sensors on E-Bikes

How Does the Torque Sensor Work:

The torque sensor measures how hard riders are pedaling. If riders pedal harder, the motor gives more power. If riders pedal lightly, the motor reduces power. This helps match the bike’s power to riders’ effort, which makes a very smooth and natural feel when riding.

Smooth and Natural Ride Feel:

Torque Sensor: It feels how hard riders are pedaling and gives assistance accordingly. The feel is more riders are pedaling with extra help rather than being pushed by a motor.

Cadence Sensor: It measures how fast riders are pedaling, then gives assistance correspondingly. Sometimes, this could give riders kind of an unnatural feel, especially starting from a standstill.

Effective Use of Power:

Torque Sensor: It only outputs power when riders need it, and in the correct quantity, thus extending the life of the battery and increasing the bike’s range.

Cadence Sensor: It provides consistent power, completely independent of pedaling effort. Irregularity can soon drain the battery.

Better Control and Responsiveness:

Torque Sensor: Reacts immediately to riders’ pedaling force and adjusts the motor assistance in real-time, making it more responsive to changes in terrain or speed.

Cadence Sensor: Might have a delay in response since it only activates when the pedals start moving, which can be less effective for quick acceleration or immediate power needs.

More Comfortable Riding Experience:

Torque Sensor: The ride feels more like a regular bicycle with added help, without needing to change riders’ pedaling style to get assistance.

Cadence Sensor: It may feel less natural because riders must maintain a certain pedal speed to get consistent assistance, which might not match riders’ preferred pedaling style.

Better Adaptability:

Torque Sensor: Adapts well to different riding styles and conditions, from casual rides to intense workouts, making it suitable for a wider range of riders.

Cadence Sensor: It works better for steady, consistent riding but might not adapt as well to varied riding situations.

Improved Safety:

Torque Sensor: It provides more controlled assistance, which can enhance safety, especially in urban environments or on challenging trails where precise control is important.

Cadence Sensor: Consistent assistance can be harder to manage in complex riding scenarios, potentially affecting safety.

Make The Right Choice

Torque Sensor:

If riders want a more natural and high-performance ride, go for a torque sensor. It accurately detects how hard riders are pedaling and adjusts the motor’s power in real time. This makes riders’ ride smoother, more comfortable, and better suited for different riding conditions.

Cadence Sensor:

If riders are a casual rider or on a budget, a cadence sensor is a great choice. It’s cheaper and easier to install and maintain. Ideal for flat surfaces and leisurely rides, it provides enough assistance for everyday use, even though it’s not as precise as a torque sensor.

Or, Riders Can Choose Magicycle Ocelot Pro 2.0

The one-click sensor switching function of Magicycle Ocelot Pro 2.0 allows riders to freely switch between the torque sensor and cadence sensor, so riders don’t have to struggle between the two sensors. Regardless of the type of rider riders are, Magicycle Ocelot Pro 2.0 is riders’ perfect choice.

Email: marketing@magicyclebike.com

Media Contact
Company Name: Magicycle
Contact Person: Janice
Email: Send Email
Country: United States
Website: https://magicyclebike.com/

Vooglam Unveils Four Exclusive Designer Half-Frame Glasses

“Where eyewear becomes an expression of you. Explore our fashion-forward designs that empower self-expression and celebrate individuality, making every pair a statement piece.”

Discover Vooglam’s latest collection of fashion-forward eyewear with the launch of four exclusive designer half-frame horn-rimmed glasses. This new collection combines classic styles with contemporary design elements, perfect for making a bold statement.

Vooglam, a leading name in the fashion eyewear industry, is thrilled to announce the launch of its latest collection: four exclusive designer half-frame horn-rimmed glasses. This new collection embodies the brand’s commitment to combining style, functionality, and innovation in eyewear fashion.

Embrace the Chic and Versatile Style of Half Frame Glasses

The new collection is designed to cater to fashion-forward individuals who seek to make a bold statement with their eyewear. These half-frame glasses offer a unique blend of classic horn-rimmed styles and contemporary design elements, making them a perfect accessory for any occasion. The collection includes the following standout designs:

Dardhan Rectangle Multicolor Eyeglasses

Featuring a vibrant multicolor design, these rectangular frames are perfect for those who love to express their personality through bold fashion statements.

Manley Round Tortoise Eyeglasses

These round tortoise frames offer a timeless look with a modern twist, combining the elegance of classic horn-rimmed glasses with the practicality of half-frame design.

Danyale Square Brown/Tortoise Eyeglasses

With a sophisticated brown and tortoise pattern, these square frames are ideal for those who appreciate understated elegance and superior craftsmanship.

Hannah Heart Pattern Eyeglasses

The heart pattern design adds a playful and romantic touch to these frames, making them a delightful choice for anyone looking to add a bit of fun to their eyewear collection.

“Never Be Boxed In” Philosophy

Vooglam’s new collection is inspired by the brand’s philosophy of living life without limitations. The “Never Be Boxed In” mantra encourages individuals to break free from conventional norms and celebrate their unique identities. Each pair of glasses in this collection is crafted to embody elegance, inspiration, style, and love—values that Vooglam holds dear.

Special Launch Offer

To celebrate the launch of this exclusive collection, Vooglam is offering a special promotion: Free Standard Shipping on orders over $59 for customers in the US, CA, UK, FR, DE, NL, ES, IE, and SG. Additionally, customers can enjoy a 50% discount on additional frames when they purchase at least two frames from the collection.

Customer Reviews

Early adopters of the new half-frame horn-rimmed glasses have shared their enthusiastic feedback. One customer remarked, “I love these glasses, and they make me feel like a sexy librarian. They fit really comfortably and the lenses are good quality.” Another customer noted, “These glasses are comfortable and well-made! I hope I can wear them on days I do not feel like wearing my contact lenses.”

About Vooglam

Vooglam is renowned for its innovative and stylish eyewear collections. The brand is dedicated to providing high-quality, fashionable glasses that cater to diverse tastes and preferences. Vooglam’s mission is to help individuals express their unique styles and live life without boundaries.

For more information about the new half-frame horn-rimmed glasses collection and to make a purchase, please visit Vooglam’s Half Frame Glasses Collection.

Contact:

Vooglam Media RelationsEmail: socialk@vooglam.com

Website: https://www.vooglam.com

Follow Us:

Facebook | Instagram | Twitter | Pinterest

Media Contact
Company Name: Vooglam
Contact Person: Byron
Email: Send Email
Phone: 3023097808
City: Austin
State: Texas
Country: United States
Website: https://www.vooglam.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vooglam Unveils Four Exclusive Designer Half-Frame Glasses

Anoka Family Paving Highlights Factors to Consider When Starting an Asphalt Paving Project

Anoka Family Paving is a top-rated asphalt paving company. In a recent update, the company highlighted factors to consider when starting an asphalt paving project.

Anoka, MN – In a website post, Anoka Family Paving highlighted factors to consider when starting an asphalt paving project.

The paving contractor Anoka mentioned that the type of asphalt material plays a crucial role in determining the durability and longevity of the pavement. Different asphalt mixes, such as hot mix asphalt (HMA) or warm mix asphalt (WMA), offer varying benefits with regard to cost-effectiveness, environmental impact, and performance under different weather conditions. Choosing the appropriate mix that aligns with the project’s specific needs is essential to achieving satisfactory results.

The technicians affirmed that climate and weather conditions in the project area significantly influence the effectiveness of asphalt paving Anoka. Extreme temperatures, precipitation levels, and seasonal changes can affect the installation and curing process of asphalt. Contractors must assess these factors to determine the optimal time for paving and apply suitable techniques to ensure proper bonding and adherence to the underlying surface.

The asphalt contractor Anoka added that proper preparation of the sub-base and base layers is critical for the stability and longevity of asphalt pavement. Adequate compaction of the underlying soil and aggregates ensures a solid foundation that supports the asphalt surface. Neglecting this preparation phase can lead to premature pavement failures, such as cracking, rutting, or uneven settlement. Contractors should employ professional techniques and equipment to achieve uniform compaction and thickness throughout the paving area.

About Anoka Family Paving

Anoka Family Paving is a premier asphalt paving company. Known for its meticulous attention to detail and dedication to customer satisfaction, the firm takes pride in every project it undertakes. The team comprises skilled professionals adept at utilizing the latest strategies and equipment to ensure superior results in every asphalt paving endeavor. Anoka Family Paving strives to exceed client expectations while maintaining a solid commitment to environmental responsibility.

Anoka Family Paving

1001 Lund Blvd #107 Anoka MN 55303

(763) 343-7917

Media Contact
Company Name: Anoka Family Paving
Contact Person: Herman Moore
Email: Send Email
Phone: (763) 343-7917
City: Anoka
State: Minnesota
Country: United Kingdom
Website: https://anokafamilypaving.com/

The Call for Goldreed Industrial Design Award Hosted by the Xiongan Future Industrial Design Institute with a 10-Day Countdown

Xiongan, China – Organized by Xiongan Future Industrial Design Institute, the Goldreed Industrial Design Award was officially opened on April 1. June 29 is the 10th day of the countdown to the Goldreed Industrial Design Award call for entries. The regular deadline ends on 8 July.

Award Positioning

With the support of People’s Government of Hebei Province and Xiongan New Area Administrative Committee, Goldreed Industrial Design Award (“GIDA” for short) was established in 2019. It is an international design prize driven by globalization, specialization and market orientation, hosted by Xiongan Future Industrial Design Institute (hereinafter referred as the “Organizer”) and undertaken by Goldreed Industrial Design Award Organizing Committee (hereinafter referred as the “Organizing Committee”).

Focusing on the principle of “facing the future, contributing oriental wisdom, and spreading design values and spirits to create a better life for mankind,” GIDA aims to build an international, specialized industrial design award that reflects both eastern and western style. Taking information society and sustainable development as the foothold, GIDA gathers global design talent resources, discovers the future design, inspires future life and enables the future city. Committed to the Chinese philosophy of “harmony and peace,” GIDA perceives technological progress and social revolution from an eastern perspective, promotes a new direction of industrial development, and creates a new way of social life in which symbiosis will be reached among man, nature, and cities.

Award Classification

Entry Categories

Registration Time and Fee

The registration for GIDA this year started on April 1, 2024 and ends at 24:00, July 8, 2024 (Beijing time). Registration at other times will not be accepted. Any changes will be notified separately.

The 5th GIDA does not charge any registration fees, but other expenses caused by logistics, insurance, customs clearance and travel for the competition shall be covered by entrants themselves.

Find the way to the registration right here: www.goldreedaward.org/en

Goldreed Industrial Design Award looks forward to all great designs!

Media Contact
Company Name: Goldreed Industrial Design Award Committee
Contact Person: Ruby Zhang
Email: Send Email
Phone: 0312-5675515
Country: China
Website: www.goldreedaward.org/en